Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis’ breakthrough cancer treatment receives FDA advisory approval

July 13, 2017
Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

News
brexit

UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators

July 13, 2017
Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …

News
pascal_soriot

AstraZeneca’s CEO set for shock switch to Teva

July 13, 2017
Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

News

Ocular slapped with CRL despite last-ditch efforts

July 12, 2017
Dextenza, Ocular Therapeutix, biotech, drugs, pharma, pharmaceutical

Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …

News

Enterome bolsters board with new executive appointment

July 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Enterome, biotech, drugs, healthcare, pharma, pharmaceuticals

Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …

Appointment
francesco_maria_lavino

Nabriva Therapeutics recruit new COO

July 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …

Appointment
teva_copy

Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm

July 12, 2017
Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …

News

Stada takeover back in motion after revised bid

July 12, 2017
Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical

Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …

News
blood_bags

Contaminated blood inquiry to probe thousands of deaths

July 12, 2017
Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical

UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …

News
mouse

Investigational drug found to boost treatment efficacy in paediatric brain cancer

July 12, 2017
Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical

Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …

News
fda2outsideweb

Plot twist as FDA U-turns on Amicus drug decision

July 11, 2017
Research and Development, Sales and Marketing Amicus Therapeutics, FDA, Galafold

The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …

News

Sanofi snatches up Protein Sciences for $750 million

July 11, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences

French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …

News
vaccine

Hope in quest for gonorrhoea vaccination

July 11, 2017
Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination

Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …

News

Ipsen secures NICE approval for multi-targeting kidney cancer therapy

July 11, 2017
Manufacturing and Production, Sales and Marketing Cabometyx, Kidney cancer, NICE

Ipsen has announced that its therapy Cabometyx (cabozantinib) has been given approval by NICE for the treatment of advanced renal …

News

ABPI launches legal action to overturn £20m price cap

July 11, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE

When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …

News
walnut

Brain tumours to be used to manufacture stem cells

July 10, 2017
Manufacturing and Production, Research and Development Censo Biotechnologies, University of Leeds

Censo Biotechnologies has announced that it will collaborate with the University of Leeds to use the latest stem cell technology …

News
brenda-fitzgerald-2

New director of CDC courts controversy from all angles

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US

It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …

Appointment
shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …

Feature

Endo withdraws product as FDA secures step in opioid crisis fightback

July 10, 2017
Sales and Marketing Endo pharmaceuticals, FDA, Opana ER

The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …

News
shutterstock_2

Problematic facility inspection puts Biocon’s biosimilar EU approvals on hold

July 10, 2017
Manufacturing and Production, Sales and Marketing Biocon, India, biosimilars

Indian firm Biocon has been hit by regulator criticism which has forced its European biosimilar programme on hold following a …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026